Topics
October 2015 | Special Focus: Uveitis
Promising Pipeline for Treatment of Noninfectious Posterior Uveitis
Agents and delivery mechanisms in development may offer physicians assistance in treating this heterogeneous disorder.
Steven Yeh, MD
August 7, 2026
UK Study Finds Ophthalmic Clinical Letters Increasingly Difficult for Patients to Read
August 6, 2026
Norlase Expands European Footprint with Direct Sales Model in Germany
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
